NIH-funded research R21 grant

Investigating how early life gut bacteria affect skin health

Official title: Early life dysbiosis, and skin barrier function

Funded at University of Cincinnati · NIH-10988301 · Data updated 2026-11-12

This study is looking at how the bacteria in young children's guts might affect their skin health, especially for kids under 11, and it wants to find out if things like being born by C-section or taking antibiotics can change those bacteria and lead to skin issues like allergies or asthma.

More Dysbiosis research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Cincinnati
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startNovember 17, 2023
Project endOctober 31, 2025
Funding year2025
Award (this year)$234,488
NIH project number5R21AI176276-02
Project IDNIH-10988301 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children under 11 years old who have experienced early life dysbiosis or are at risk for allergic diseases.

Less likely to help

Patients who are older than 11 years or do not have a history of allergic diseases may not benefit from this research.

What this research studies

This research explores the connection between early life gut bacteria and skin barrier function, particularly in children under 11 years old. It examines how environmental factors, such as C-section delivery and antibiotic use, can alter microbial composition in infants, potentially leading to allergic diseases like asthma and dermatitis. The study aims to understand how these changes in gut bacteria can affect skin permeability and overall skin health. By analyzing gene expression related to skin barrier function, the research seeks to identify potential therapeutic interventions to improve skin health in affected children.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating allergic diseases in children by improving skin barrier function.

How similar studies have gone: Previous research has shown promising results in understanding the role of gut bacteria in skin health, indicating that this approach has potential for success.

Where this research is happening

  • University of Cincinnati
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Ghosh, Debajyoti — University of Cincinnati
  • Study coordinator: Ghosh, Debajyoti

Related research

Other NIH-funded projects on the same topics.

  • Microbial Dysbiosis and Its Role in Pancreatic Cancer

    A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.

    NIH research Northwestern University · Chicago, United States · NIH-11624054

  • From Symbiosis to Dysbiosis: How Resolving Inflammation Could Restore Your Mouth’s Balance

    This grant explores how turning off the harmful inflammation in periodontitis and promoting natural healing could help restore the mouth’s healthy balance.

    NIH research Ada Forsyth Institute, INC. · Somerville, UNITED STATES · NIH-11621747

  • Antibiotics, gut health, and skin reactions in kids

    A small study in children will look at whether antibiotic use and gut bacteria play a role in hives and related symptoms that children sometimes get after antibiotics.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11603169

  • Novel therapeutic to protect the gut after radiation

    A new GI-directed treatment given after radiation exposure may reduce gut damage and improve survival in people exposed to high-dose radiation.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572662

  • A new GI-focused treatment to reduce radiation damage after exposure

    A potential GI-targeted therapy given after radiation exposure may help protect the gut and improve survival in people affected by radiation injuries.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572658

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.